Free Trial

Charles River Laboratories International (CRL) Stock Forecast & Price Target

Charles River Laboratories International logo
$177.96 -3.72 (-2.05%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$177.60 -0.35 (-0.20%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Charles River Laboratories International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
4
Buy
11

Based on 16 Wall Street analysts who have issued ratings for Charles River Laboratories International in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 1 has given a sell rating, 4 have given a hold rating, and 11 have given a buy rating for CRL.

Consensus Price Target

$205.86
15.68% Upside
According to the 16 analysts' twelve-month price targets for Charles River Laboratories International, the average price target is $205.86. The highest price target for CRL is $265.00, while the lowest price target for CRL is $160.00. The average price target represents a forecasted upside of 15.68% from the current price of $177.96.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CRL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRL Analyst Ratings Over Time

TypeCurrent Forecast
5/10/25 to 5/10/26
1 Month Ago
4/10/25 to 4/10/26
3 Months Ago
2/9/25 to 2/9/26
1 Year Ago
5/10/24 to 5/10/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
10 Buy rating(s)
10 Buy rating(s)
1 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
13 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$205.86$206.15$209.46$176.00
Forecasted Upside15.68% Upside17.42% Upside12.90% Upside26.76% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyHold

CRL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Charles River Laboratories International Stock vs. The Competition

TypeCharles River Laboratories InternationalMedical CompaniesS&P 500
Consensus Rating Score
2.63
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside15.68% Upside858.42% Upside15.49% Upside
News Sentiment Rating
Positive News

See Recent CRL News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/8/2026
Robert W. Baird logo
Robert W. Baird
3 of 5 stars
Eric Coldwell
Eric Coldwell
2 of 5 stars
Set Target$213.00+20.60%
5/8/2026
Evercore Inc logo
Evercore
3 of 5 stars
 Reiterated RatingOutperform$220.00+24.47%
5/8/2026
Mizuho logo
Mizuho
3 of 5 stars
 Set Target$192.00+8.62%
5/8/2026Boost TargetOverweight$210.00 ➝ $220.00+20.91%
4/20/2026 Reiterated RatingSell (D)
4/14/2026 Initiated CoverageOutperform$215.00+20.74%
4/13/2026Lower TargetNeutral$165.00 ➝ $160.00-10.17%
2/25/2026Boost TargetNeutral$170.00 ➝ $175.00+3.97%
2/20/2026Lower TargetBuy$251.00 ➝ $235.00+41.87%
1/16/2026Boost TargetBuy$200.00 ➝ $265.00+18.76%
12/15/2025 UpgradeNeutralBuy$225.00+16.61%
12/1/2025Set Target$185.00+4.86%
11/17/2025 Set Target$200.00+19.85%
10/6/2025UpgradeMarket PerformOutperform
9/9/2025UpgradeHoldBuy$142.00 ➝ $195.00+20.39%
5/23/2025UpgradeNeutralBuy$188.00 ➝ $182.00+34.38%
3/21/2025DowngradeBuyNeutral$190.00 ➝ $170.00+2.71%
11/18/2024 DowngradeHoldUnderperform$164.00-12.65%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 05:41 AM ET.


CRL Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Charles River Laboratories International is $205.86, with a high forecast of $265.00 and a low forecast of $160.00.

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Charles River Laboratories International in the last twelve months. There is currently 1 sell rating, 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRL shares.

According to analysts, Charles River Laboratories International's stock has a predicted upside of 15.68% based on their 12-month stock forecasts.

Charles River Laboratories International has been rated by research analysts at Barclays, Evercore, JPMorgan Chase & Co., Mizuho, Robert W. Baird, Royal Bank Of Canada, TD Cowen, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Charles River Laboratories International more than other "medical" companies. The consensus rating for Charles River Laboratories International is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CRL compares to other companies.


This page (NYSE:CRL) was last updated on 5/10/2026 by MarketBeat.com Staff.
From Our Partners